@article{572fc7f1309b42ba80d63695b1f8dfef,
title = "Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation",
abstract = "Background: The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age groups. Estimates suggest that people with diabetes die, on average, 6 years earlier than people without diabetes. We aimed to provide reliable estimates of the associations between age at diagnosis of diabetes and all-cause mortality, cause-specific mortality, and reductions in life expectancy. Methods: For this observational study, we conducted a combined analysis of individual-participant data from 19 high-income countries using two large-scale data sources: the Emerging Risk Factors Collaboration (96 cohorts, median baseline years 1961–2007, median latest follow-up years 1980–2013) and the UK Biobank (median baseline year 2006, median latest follow-up year 2020). We calculated age-adjusted and sex-adjusted hazard ratios (HRs) for all-cause mortality according to age at diagnosis of diabetes using data from 1 515 718 participants, in whom deaths were recorded during 23·1 million person-years of follow-up. We estimated cumulative survival by applying age-specific HRs to age-specific death rates from 2015 for the USA and the EU. Findings: For participants with diabetes, we observed a linear dose–response association between earlier age at diagnosis and higher risk of all-cause mortality compared with participants without diabetes. HRs were 2·69 (95\% CI 2·43–2·97) when diagnosed at 30–39 years, 2·26 (2·08–2·45) at 40–49 years, 1·84 (1·72–1·97) at 50–59 years, 1·57 (1·47–1·67) at 60–69 years, and 1·39 (1·29–1·51) at 70 years and older. HRs per decade of earlier diagnosis were similar for men and women. Using death rates from the USA, a 50-year-old individual with diabetes died on average 14 years earlier when diagnosed aged 30 years, 10 years earlier when diagnosed aged 40 years, or 6 years earlier when diagnosed aged 50 years than an individual without diabetes. Using EU death rates, the corresponding estimates were 13, 9, or 5 years earlier. Interpretation: Every decade of earlier diagnosis of diabetes was associated with about 3–4 years of lower life expectancy, highlighting the need to develop and implement interventions that prevent or delay the onset of diabetes and to intensify the treatment of risk factors among young adults diagnosed with diabetes. Funding: British Heart Foundation, Medical Research Council, National Institute for Health and Care Research, and Health Data Research UK.",
author = "S. Kaptoge and Seshasai, \{S. R.K.\} and L. Sun and M. Walker and T. Bolton and S. Spackman and F. Ataklte and P. Willeit and S. Bell and S. Burgess and L. Pennells and S. Altay and G. Assmann and Y. Ben-Shlomo and Best, \{L. G.\} and C. Bj{\"o}rkelund and Blazer, \{D. G.\} and H. Brenner and Brunner, \{E. J.\} and Dagenais, \{G. R.\} and Cooper, \{J. A.\} and C. Cooper and Crespo, \{C. J.\} and M. Cushman and D'Agostino, \{R. B.\} and M. Daimon and Daniels, \{L. B.\} and R. Danker and Davidson, \{K. W.\} and \{de Jongh\}, \{R. T.\} and C. Donfrancesco and P. Ducimetiere and Elders, \{P. J.M.\} and G. Engstr{\"o}m and I. Ford and I. Gallacher and Bakker, \{S. J.L.\} and U. Goldbourt and \{de La C{\'a}mara\}, G. and S. Grimsgaard and V. Gudnason and Hansson, \{P. O.\} and H. Imano and Jukema, \{J. W.\} and C. Kabrhel and J. Kauhanen and M. Kavousi and S. Kiechl and Knuiman, \{M. W.\} and D. Kromhout and Krumholz, \{H. M.\} and Kuller, \{L. H.\} and T. Laatikainen and Lowler, \{D. A.\} and Meyer, \{H. E.\} and K. Mukamal and Nietert, \{P. J.\} and T. Ninomiya and D. Nitsch and Nordestgaard, \{B. G.\} and L. Palmieri and Price, \{J. F.\} and Ridker, \{P. M.\} and Q. Sun and A. Rosengren and R. Roussel and M. Sakurai and V. Salomaa and B. Sch{\"o}ttker and Shaw, \{J. E.\} and Strandberg, \{T. E.\} and J. Sundstr{\"o}m and H. Tolonen and A. Tverdal and Verschuren, \{W. M.M.\} and H. V{\"o}lzke and L. Wagenknecht and Wallace, \{R. B.\} and Wannamethee, \{S. G.\} and Wareham, \{N. J.\} and S. Wassertheil-Smoller and K. Yamagishi and Yeap, \{B. B.\} and S. Harrison and M. Inouye and S. Griffin and Butterworth, \{A. S.\} and Wood, \{A. M.\} and Thompson, \{S. G.\} and N. Sattar and J. Danesh and \{Di Angelantonio\}, E. and Tipping, \{R. W.\} and S. Russell and M. Johansen and Bancks, \{M. P.\} and M. Mongraw-Chaffin and D. Magliano and Barr, \{E. L.M.\} and Zimmet, \{P. Z.\} and Whincup, \{P. H.\} and J. Willeit and C. Leitner and Lawlor, \{D. A.\} and P. Elwood and Sutherland, \{S. E.\} and Hunt, \{K. J.\} and Selmer, \{R. M.\} and Haheim, \{L. L.\} and I. Ariansen and A. Tybjaer-Hansen and R. Frikkle-Schmidt and A. Langsted and \{Lo Noce\}, C. and B. Balkau and F. Bonnet and F. Fumeron and Pablos, \{D. L.\} and Ferro, \{C. R.\} and Morales, \{T. G.\} and S. Mclachlan and J. Guralnik and Khaw, \{K. T.\} and B. Holleczek and H. Stocker and A. Nissinen and E. Vartiainen and P. Jousilahti and K. Harald and Massaro, \{J. M.\} and M. Pencina and A. Lyass and S. Susa and T. Oizumi and T. Kayama and A. Chetrit and J. Roth and L. Orenstein and L. Welin and K. Sv{\"a}rdsudd and L. Lissner and D. Hange and K. Mehlig and Tilvis, \{R. S.\} and E. Dennison and L. Westbury and Norman, \{P. E.\} and Almeida, \{O. P.\} and Hankey, \{G. J.\} and J. Hata and M. Shibata and Y. Furuta and Bom, \{M. T.\} and F. Rutters and M. Muilwijk and P. Kraft and S. Lindstrom and C. Turman and M. Kiyama and A. Kitamura and Y. Gerber and Salonen, \{J. T.\} and \{van Schoor\}, \{L. N.\} and \{van Zutphen\}, \{E. M.\} and O. Melander and Psaty, \{B. M.\} and M. Blaha and \{de Boer\}, \{I. H.\} and Kronmal, \{R. A.\} and G. Grandits and Shin, \{H. C.\} and Albertorio, \{J. R.\} and Gillum, \{R. F.\} and Hu, \{F. B.\} and S. Humphries and \{Hill- Briggs\}, F. and E. Vrany and M. Butler and Schwartz, \{J. E.\} and H. Iso and P. Amouyel and D. Arveiler and J. Ferrieres and Gansevoort, \{R. T.\} and \{de Boer\}, R. and L. Kieneker and S. Trompet and P. Kearney and B. Cantin and Despr{\'e}s, \{J. P.\} and B. Lamarche and G. Laughlin and L. McEvoy and T. Aspelund and B. Thorsson and G. Sigurdsson and M. Tilly and Ikram, \{M. A.\} and M. Dorr and S. Schipf and Fretts, \{A. M.\} and Umans, \{J. G.\} and T. Ali and N. Shara and G. Davey-Smith and G. Can and H. Y{\"u}ksel and U. {\"O}zkan and H. Nakagawa and Y. Morikawa and M. Ishizaki and I. Nj{\o}lstad and T. Wilsgaard and E. Mathiesen and J. Buring and N. Cook and V. Arndt and D. Rothenbacher and J. Manson and L. Tinker and M. Shipley and Tabak, \{A. G.\} and M. Kivimaki and C. Packard and M. Robertson and E. Feskens and M. Geleijnse and \{Emerging Risk Factors Collaboration\}",
note = "Funding Information: This research was conducted using the UK Biobank Resource under application number 13784. No specific funding was obtained for this manuscript. The coordinating centre was supported by core funding from the British Heart Foundation (RG/18/13/33946), Cambridge BHF Centre of Research Excellence (RE/18/1/34212) and BHF Chair Award (CH/12/2/29428), and NIHR Cambridge Biomedical Research Centre (BRC-1215-20014; NIHR203312). JD holds a BHF Professorship and an NIHR Senior Investigator Award. AMW is part of the BigData@Heart Consortium, funded by the Innovative Medicines Initiative-2 Joint Undertaking under grant agreement 116074 and is supported by the BHF-Turing Cardiovascular Data Science Award (BCDSA\textbackslash{}100005). MI is supported by the Munz Chair of Cardiovascular Prediction and Prevention and by the UK Economic and Social Research 878 Council (ES/T013192/1). EDA holds a NIHR Senior Investigator Award. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} 2023",
year = "2023",
month = oct,
doi = "10.1016/S2213-8587(23)00223-1",
language = "English",
volume = "11",
pages = "731--742",
journal = "The Lancet Diabetes and Endocrinology",
issn = "2213-8587",
publisher = "Elsevier",
number = "10",
}